The Quadrivalent Approach to Influenza Vaccination

被引：16
|
作者：
Dolin, Raphael [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2013年 / 208卷 / 04期
关键词：
influenza; influenza B; influenza vaccine; quadrivalent influenza vaccine; inactivated influenza vaccine; live attenuated influenza vaccine; IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; VACCINES; IMMUNOGENICITY; CHILDREN; SAFETY; ADULTS; RECOMMENDATIONS; PREVENTION; IMPACT;
D O I：
10.1093/infdis/jit264
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
    Brogan, Anita J.
    Talbird, Sandra E.
    Davis, Ashley E.
    Thommes, Edward W.
    Meier, Genevieve
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 533 - 542
  • [2] Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
    Gresset-Bourgeois, Viviane
    Leventhal, Phillip S.
    Pepin, Stephanie
    Hollingsworth, Rosalind
    Kazek-Duret, Marie-Pierre
    De Bruijn, Iris
    Samson, Sandrine I.
    EXPERT REVIEW OF VACCINES, 2018, 17 (01) : 1 - 11
  • [3] A systematic review of the health economic consequences of quadrivalent influenza vaccination
    de Boer, Pieter T.
    van Maanen, Britt M.
    Damm, Oliver
    Ultsch, Bernhard
    Dolk, Franklin C. K.
    Crepey, Pascal
    Pitman, Richard
    Wilschut, Jan C.
    Postma, Maarten J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (03) : 249 - 265
  • [4] Predictors of influenza vaccination in the US among children 9-13 years of age
    Imburgia, Teresa M.
    Hendrix, Kristin S.
    Donahue, Kelly L.
    Sturm, Lynne A.
    Zimet, Gregory D.
    VACCINE, 2017, 35 (18) : 2338 - 2342
  • [5] Fluarix quadrivalent vaccine for influenza
    de Graaf, Hans
    Faust, Saul N.
    EXPERT REVIEW OF VACCINES, 2015, 14 (08) : 1055 - 1063
  • [6] Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
    de Boer, Pieter T.
    Crepey, Pascal
    Pitman, Richard J.
    Macabeo, Berengere
    Chit, Ayman
    Postma, Maarten J.
    VALUE IN HEALTH, 2016, 19 (08) : 964 - 975
  • [7] Quadrivalent influenza vaccine in the United States
    Suryadevara, Manika
    Domachowske, Joseph B.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (03) : 596 - 599
  • [8] Fluzone® Intradermal Quadrivalent Influenza Vaccine
    Robertson, Corwin A.
    Tsang, Peter
    Landolfi, Victoria A.
    Greenberg, David P.
    EXPERT REVIEW OF VACCINES, 2016, 15 (10) : 1245 - 1253
  • [9] Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis
    Tao, Yan-Yang
    Li, Jing-Xin
    Hu, Yue-Mei
    Hu, Yuan-Sheng
    Zeng, Gang
    Zhu, Feng-Cai
    EXPERT REVIEW OF VACCINES, 2021, 20 (01) : 1 - 11
  • [10] Retrospective public health impact of a quadrivalent influenza vaccine in the United States
    Crepey, Pascal
    de Boer, Pieter T.
    Postma, Maarten J.
    Pitman, Richard
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2015, 9 : 39 - 46
12345